Epigenetic Features of FoxP3 in Children With Cow's Milk Allergy

Status Completed

Clinical Trial Summary

Epigenetic mechanisms have been implicated in the pathogenesis of food allergy. The investigators previously demonstrated that tolerance acquisition in children with Immunoglobulin E- (IgE) mediated cow's milk allergy (CMA) is driven by epigenetic modulation of the Th1 and Th2 cytokine genes. A regulatory T cell (Treg) suppressive phenotype, characterized by stable expression of the transcription factor "Forkhead box Protein 3" (FoxP3), plays a pivotal role in food tolerance. FoxP3 mRNA expression is lower in children with atopic asthma or IgE-mediated food allergy than in healthy children. FoxP3 stable expression requires full CpG demethylation of its transcriptional regulatory regions, and, moreover, hypermethylation of the FoxP3 gene has been associated with reduced Treg function and allergy.

DNA methylation is a biologically and chemically stable epigenetic modification that locks in long-term gene expression patterns. The demethylation status of FoxP3 at a highly conserved region within the Treg-specific-demethylated-region (TSDR), a CpG-rich, located on the 2nd conserved non-coding sequence of FoxP3 (CNS2), is restricted to Tregs. Transcriptional activity of the TSDR is essentially determined by its methylation status : it is completely inactive in its methylated state, but when the TSDR is demethylated, transcription factors such as Ets-1 and Creb can bind to the TSDR. TSDR demethylated and open chromatin conformation in the Foxp3 locus leads to stable phenotype differentiated Foxp3+ Treg. FoxP3 TSDR demethylation in peripheral blood mononuclear cells (PBMCs) has been associated with reduced atopic sensitization and asthma in children. Epigenetic regulation of antigen-induced T-cell subsets may predict a state of immune tolerance in food allergy. Indeed, DNA methylation of the FoxP3 gene in Tregs decreased during oral tolerance acquisition in patients with peanut allergy undergoing oral immunotherapy. The aim of this study was to evaluate further the epigenetic regulation of FoxP3 gene in children with IgE-mediated CMA.

Clinical Trial Description

n/a

Study Design

Observational Model: Case-Crossover, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02779881
Study type	Observational
Source	Federico II University
Contact
Status	Completed
Phase	N/A
Start date	December 2012
Completion date	April 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02738060` - The Effect of Baked Milk on Cow's Milk Allergy	Phase 2
Recruiting	`NCT02149134` - Evaluation of the Efficacy of a New Infant Formula in Subjects With Cow's Milk Allergy	Phase 2
Recruiting	`NCT01891916` - Effect Of Lactobacillus GG on Atopic March	N/A
Completed	`NCT01634490` - Effects of Different Dietary Regimens on Tolerance Acquisition in Children With Cow's Milk Allergy	N/A
Completed	`NCT01622426` - Tolerance to a New Free Amino Acid-based Formula in Children With IgE or Non-IgE-mediated Cow's Milk Allergy	N/A
Completed	`NCT02466035` - Epigenetic Effects Involved in Children With Cow's Milk Allergy (EPICMA)	N/A
Completed	`NCT02379598` - Effect of Therapy With Aminoacid Based Formula Versus Hydrolyzed Whey Proteins in Children With Cow's Milk Allergy	N/A
Completed	`NCT04330092` - Diagnosis of Cow's Milk Protein Allergy
Not yet recruiting	`NCT02081651` - Parmigiano-Reggiano Cheese as a Possible Strategy to Acquire Oral Tolerance in Children With Cow's Milk Allergy	Phase 3
Completed	`NCT03462030` - Baked Milk Oral Immunotherapy for Cow's Milk Allergy	Phase 2
Completed	`NCT02465905` - Oral Immunotherapy in Cow's Milk Allergy (CMA) in Children : "Petit Lait" Study	N/A
Suspended	`NCT05731206` - Hypoallergenicity of a Hydrolyzed Protein Infant Formula	N/A
Not yet recruiting	`NCT06456541` - Infant Formula in Infants and Children With Cow's Milk Allergy	N/A
Recruiting	`NCT02062476` - Epigenetic Effects Elicited By Lactobacillus GG In Children With Cow's Milk Allergy	Phase 2
Completed	`NCT01589731` - Polymerized Beta-lactoglobulin Comparative Immunoreactivity	N/A
Terminated	`NCT02405923` - Growth, Safety and Tolerance of a Rice Protein Hydrolysate Formula in Infants With Cow's Milk Protein Allergy	N/A
Terminated	`NCT04910373` - Extensively Hydrolyzed Infant Formula in Infants and Children With Cow's Milk Allergy	N/A
Recruiting	`NCT01968278` - Use of Baked Milk in Oral Immunotherapy for Severe IgE-mediated Cow's Milk Protein Allergic Patients	N/A
Withdrawn	`NCT01470768` - Evaluation of Fatty Acid Levels and Growth in Infants Fed Amino Acid Based (AA) Formulas	N/A
Recruiting	`NCT05883384` - Validity of Cow's Milk-related Symptom Score Among Children Suspected to Have Cow's Milk Protein Alergy